|
⚲
|
| Keyboard |
| Korenberg Matthew E
✚
|
|
|---|---|
| CIK # | 0001649903 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001649903] | |
| 4 | [0001649903] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Palvella Therapeutics Inc | |
| Korenberg Matthew E | |
| Lifecore Biomedical Inc de | |
| Ligand Pharmaceuticals Inc | |
| Ritter Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Palvella Therapeutics Inc PVLA
Stock Option (Right to Buy) · derivative
|
2026-02-05 | Grant | 44,123 | $0.00 | |
|
Lifecore Biomedical Inc de LFCR
Common Stock
|
2025-07-15 | Grant | 19,506 | ||
|
Palvella Therapeutics Inc PVLA
Stock Option (right to buy) · derivative
|
2024-12-13 | Grant | 167,100 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-23 | Sell | 7,090 | $101.61 | 720,415 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2024-09-23 | Option exercise | 9,377 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2024-09-23 | Option exercise | 395 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-23 | Option exercise | 395 | $49.99 | 19,746 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-23 | Sell | 201 | $102.05 | 20,512 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-23 | Sell | 2,481 | $100.05 | 248,224 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-23 | Option exercise | 9,377 | $52.84 | 495,481 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2024-09-20 | Option exercise | 4,982 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-20 | Option exercise | 4,982 | $49.99 | 249,050 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-20 | Sell | 6,275 | $104.10 | 653,228 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Tax withheld | 1,938 | $105.00 | 203,490 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Option exercise | 849 | $58.49 | 49,658 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Option exercise | 914 | $55.75 | 50,956 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Option exercise | 3,340 | $60.94 | 203,540 |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Tax withheld | 319 | $105.00 | 33,495 |
|
Ligand Pharmaceuticals Inc LGND
Employee Stock Option (right to buy) · derivative
|
2024-09-16 | Option exercise | 3,340 | $0.00 | |
|
Ligand Pharmaceuticals Inc LGND
Common Stock
|
2024-09-16 | Option exercise | 671 | $49.99 | 33,543 |
| showing 20 of 120 most recent transactions | |||||